- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03455569
A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In 2015, Americans provided 18 billion hours of unpaid care for patients with Alzheimer's disease (AD) and other dementias, with an economic value of $221 billion. This estimate may be even higher among caregivers of AD patients when they have sleep problems. In fact, the caregivers' sleep is often disturbed by nighttime sleep disturbance of AD patients, which is one of the major reasons why those patients are admitted to institutions. Due to the bidirectional nature of sleep disturbance in AD patients and their caregivers, it is critical to develop a sleep intervention program for the dyad that addresses sleep disturbance in both individuals.
Nighttime sleep disturbance in AD patients is associated with shorter survival, lower quality of life, and decreased social engagement. Poor sleep among their caregivers is associated with increased depressive symptoms, higher levels of caregiver role burden, and increased inflammation, which is known to increase risk for cardiovascular disease. Such decline in caregivers' health may then impact the quality of care for AD patients.
Behavioral sleep intervention programs for AD patients or caregivers are feasible but long-term effects on improving sleep and health remain unclear. No behavioral sleep interventions have focused on the patient-caregiver dyad, and only a few behavioral sleep intervention studies have targeted community-dwelling AD patients or caregivers. Dyad-based sleep interventions may have better effects on sleep and other health outcomes because of the influence of AD patients on their caregivers and vice versa.
The proposed intervention focuses on educating caregivers to improve their own and the patients' sleep, using behavioral sleep management techniques. This intervention builds upon a previous caregiver focus group study (VA HSR&D LIP 65-154, PI: Song) and the existing sleep interventional research studies, which included patients with mild cognitive impairments and AD patients. The sleep program involves 4 face-to-face meetings plus 1 telephone session. Phase 1 study aims to iteratively refine and finalize the intervention program materials with 5 AD patient/caregiver dyads. Phase 2 study aims to pilot test the effects of the intervention program (n=20 dyads) on sleep, health, and quality of life in both members of the group, compared to a non-directive education-only control program (n=20 dyads) in a small randomized controlled trial. Primary outcomes will include objective sleep efficiency and total wake time measured by actigraphy for AD patients and subjective sleep measured by the Pittsburgh Sleep Quality Index for caregivers. A unique aspect of the proposed study is that the program is tailored to address sleep problems of both patients and caregivers, and includes upstream biomarkers to evaluate a key mechanism of intervention benefits that can be further explored in future research.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- University of California Los Angeles
-
North Hills, California, United States, 91343
- Veterans Affairs Greater Los Angeles Healthcare System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for Alzheimer's disease (AD) patients:
- AD diagnosis OR probable or possible AD as documented in electronic medical record, which includes Mini Mental State Exam score >12 (indicating mild to moderate severity of AD) and neuroimaging evidence
- Community-dwelling
- >1 sleep problem >3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale
- Aged >60 years
- Able to ambulate with or without assistive device
- Have an eligible caregiver (see below)
Inclusion Criteria for caregivers:
- Live with an eligible patient
- Aged >21 years
- Have regularly assisted patient with >1 of 6 basic activities of daily living (ADLs) (i.e., bathing, dressing, toileting, transfers, continence, feeding) or >1 of 8 Instrumental ADL (IADLs) (i.e., using the telephone, shopping, preparing meals, housekeeping, laundry, transportation, taking medicine, managing money) for the past 6 months
- Pittsburgh Sleep Quality Index (PSQI) total score >5
- Montreal Cognitive Assessment (MoCA) score >= 23
- Can communicate in English
Exclusion Criteria:
- If AD patient is bed bound
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral sleep education
manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
|
This group will receive manual-based sleep hygiene recommendations and a behavioral sleep intervention including sleep compression therapy
|
Experimental: Education only
education on sleep, aging, and dementia but without specific or individualized recommendations
|
This group will receive information about sleep, aging, and dementia, but without specific or individualized recommendations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep efficiency for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Sleep efficiency (mean percent time asleep while in bed) will be calculated from 3 days of wrist actigraphy
|
3 months after the last session of the sleep intervention
|
Total wake time for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Total wake time (mean total minutes awake from sleep onset to get up time) will be calculated from 3 days of wrist actigraphy
|
3 months after the last session of the sleep intervention
|
Sleep quality for caregivers
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Pittsburgh Sleep Quality Index will be used as a measure of sleep quality
|
3 months after the last session of the sleep intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive function for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Alzheimer's Disease Assessment Scale-Cognitive Subscale test will be used as a measure of cognitive function
|
3 months after the last session of the sleep intervention
|
Problematic behaviors for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Revised Memory and Behavior Problem Checklist will be used as a measure of problematic behaviors
|
3 months after the last session of the sleep intervention
|
Depression for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Cornell Scale for Depression in Dementia will be used as a measure of depression
|
3 months after the last session of the sleep intervention
|
Caregiver burden for caregivers
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Zarit Burden Interview will be used as a measure of caregiver burden
|
3 months after the last session of the sleep intervention
|
Stress for caregivers
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Perceived Stress Scale will be used as a measure of stress
|
3 months after the last session of the sleep intervention
|
Depression for caregivers
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Center for Epidemiological Study-Depression will be used as a measure of depression
|
3 months after the last session of the sleep intervention
|
Inflammation for caregivers
Time Frame: 3 months after the last session of the sleep intervention
|
Levels of C-reactive protein and gene expression of inflammation will be measured
|
3 months after the last session of the sleep intervention
|
Quality of life for Alzheimer's disease patients
Time Frame: 3 months after the last session of the sleep intervention
|
Total score on the Quality of Life-Alzheimer's Disease Scale will be used as a measure of quality of life
|
3 months after the last session of the sleep intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yeonsu Song, PhD, University of California, Los Angeles
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1K23AG055668-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionEnrolling by invitation
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
Brain Electrophysiology Laboratory CompanyCompletedSleep | Sleep HygieneUnited States
-
Koko Home, Inc.Stanford UniversityRecruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep HygieneUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, Wisconsin; Divine Savior...Active, not recruitingSleep | Sleep HygieneUnited States
-
Aretaieion University HospitalRecruitingSleep Disorder | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Surgery | Anesthesia | Sleep Fragmentation | Sleep Disorders, Circadian RhythmGreece
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
Clinical Trials on Behavioral sleep education
-
University of California, Los AngelesVA Office of Research and DevelopmentRecruitingCardiovascular Diseases | Insomnia | Posttraumatic Stress Disorder | Metabolic DiseaseUnited States
-
Wayne State UniversityCompletedStress, Emotional | Sleep DisturbanceUnited States
-
University of California, Los AngelesNational Institute on Aging (NIA)Completed
-
Christopher DrakeNational Institute of Nursing Research (NINR); Wayne State University; University...Completed
-
Solveig MagnusdottirMyCardioLLCCompleted
-
Brigham and Women's HospitalThe Cleveland ClinicCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Under ArmourCompletedBreast Cancer | Insomnia | Overweight and ObesityUnited States
-
Peking UniversityCompleted
-
Solveig MagnusdottirMenntaskolin a AkureyriEnrolling by invitationDepression | Sleep | Anxiety | ChronotypeIceland
-
Dartmouth-Hitchcock Medical CenterRecruitingInsomnia | Crohn DiseaseUnited States